CD154 Recombinant Antibody [YMF323.6] (OAAV00907)

Produktübersicht

• Artikelname: CD154 Recombinant Antibody [YMF323.6] (OAAV00907)
• Artikelnummer: ASB-OAAV00907
• Hersteller Artikelnummer: OAAV00907
• Alternativnummer: ASB-OAAV00907-200UG
• Hersteller: Aviva
• Wirt: Rabbit
• Kategorie: Proteine/Peptide
• Applikation: IF, IP, WB
• Spezies Reaktivität: Human
• Immunogen: BALB/c mice were immunised with acute lymphocytic leukaemia cells from a human leukaemia patient. Splenocytes were obtained from immunised mice and fused with MOPC-21 NS/1 myeloma cells to generate a hybridoma.
• Alternative Synonym: atriopeptidase,CALLA,CD10,CMT2T,common acute lymphocytic leukemia antigen,Enkephalinase,membrane metallo-endopeptidase (neutral endopeptidase, enkephalinase, CALLA, CD10),membrane metallo-endopeptidase variant 1,membrane metallo-endopeptidase variant 2,NEP,neprilysin,neprilysin-390,neprilysin-411,neutral endopeptidase 24.11,SCA43,SFE,skin fibroblast elastase.

Produktbeschreibung

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [NL-1]
• NCBI: 4311
• UniProt: P86176
• Formulierung: PBS with 0.02% Proclin 300.

Anwendungsbeschreibung

• Application Verdünnung: Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids (PubMed:15283675, PubMed:8168535). Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Ph